The augmentation of physostigmine toxicity in the rat by    9 -tetrahydrocannabinol.
D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002188:Cannabis / Q000633:toxicity*; D013759:Dronabinol / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity; D004338:Drug Combinations; D004357:Drug Synergism; D007275:Injections, Intravenous; D010830:Physostigmine / Q000008:administration & dosage / Q000037:antagonists & inhibitors / Q000633:toxicity*; D051381:Rats; D012601:Scopolamine / Q000494:pharmacology
D004338:Drug Combinations; D001285:Atropine; D013759:Dronabinol; D010830:Physostigmine; D012601:Scopolamine